Search results
Results from the WOW.Com Content Network
Dermatophagia (from Ancient Greek δέρμα (derma) 'skin' and φαγεία (phageia) 'eating') or dermatodaxia (from δήξις (dexis) 'biting'), alternatively Tuglis Permushius. [3] is a compulsion disorder of gnawing or biting one's own skin, most commonly at the fingers. This action can either be conscious or unconscious [4] and it is ...
Specialty. Dermatology. Psychiatry. Excoriation disorder, more commonly known as dermatillomania, is a mental disorder on the obsessive–compulsive spectrum that is characterized by the repeated urge or impulse to pick at one's own skin, to the extent that either psychological or physical damage is caused. [4][5]
Damaged cuticles, shortened and damaged nails, hangnails, bleeding, etc. Nail biting, also known as onychophagy or onychophagia, is an oral compulsive and unhygienic habit of biting one's fingernails. It is sometimes described as a parafunctional activity, the common use of the mouth for an activity other than speaking, eating, or drinking.
The Federal Food and Drug Administration (FDA) has recently approved Eli Lilly’s EBGLYSS as a treatment for moderate-to-severe atopic dermatitis (eczema). EBGLYSS is now approved for adults and ...
Aphagia. Arrow pointing to hypothalamus in human brain. The hypothalamus is responsible for controlling food intake and swallowing. Specialty. Gastroenterology. Complications. Malnutrition, metabolic disorders. Aphagia is the inability or refusal to swallow. [1][2] The word is derived from the Ancient Greek prefix α, meaning "not" or "without ...
An electron micrograph of bacteriophages attached to a bacterial cell. These viruses are the size and shape of coliphage T1. Phage therapy, viral phage therapy, or phagotherapy is the therapeutic use of bacteriophages for the treatment of pathogenic bacterial infections. [ 1 ][ 2 ][ 3 ] This therapeutic approach emerged at the beginning of the ...
Loaded 0%. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers ...
The currently approved drug in the US, melarsomine, is marketed under the brand name Immiticide. [29] It has a greater efficacy and fewer side effects than the previously used drug thiacetarsamide , sold as Caparsolate, which makes it a safer alternative for dogs with late-stage infections.